Erschienen in:
01.05.2005 | Oral presentation
The role of Xeloda in metastasic breast cancer
verfasst von:
H Cortés-Funes
Erschienen in:
Breast Cancer Research
|
Sonderheft 1/2005
Einloggen, um Zugang zu erhalten
Excerpt
Currently, breast cancer is the primary reason for death due to cancer in Spanish women aged between 35 and 64 years. Nevertheless, despite detecting an increased incidence, it is observed a decrease on mortality rates, in agreement with it is observed in other European countries. This issue is basically due to the development of programs to sift and the use of widespread systemic treatments, both on early and advanced stages of the disease. During the past decade breast cancer has benefited from incorporation of new antitumor drugs to treat this kind of cancer. These new drugs are able to control, in an effective way, the progress of metastatic disease and slow down or eradicate micrometastasis in early stages. …